Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine.

NCT03902054 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

600

Enrollment

NETWORK

Sponsor class

Conditions

Polio and Post-Polio Syndrome

Interventions

BIOLOGICAL: Three-dose regimen of high dosage investigational sIPV
BIOLOGICAL: Three-dose regimen of medium dosage investigational sIPV
BIOLOGICAL: Three-dose regimen of low dosage investigational sIPV
BIOLOGICAL: Three-dose regimen of commercialized sIPV
BIOLOGICAL: Three-dose regimen of commercialized IPV

Sponsor

Jiangsu Province Centers for Disease Control and Prevention

Collaborators

[object Object]